EFFECT OF PREECLAMPSIA ON FETOPLACENTAL INSUFFICIENCY: PREGNANCY PROGRESSION AND OUTCOME
Keywords:
fetoplacental insufficiency, preeclampsiaAbstract
The aim of this study was to investigate fetoplacental insufficiency in pregnant women with preeclampsia. Methods: A prospective study involving 30 pregnant women with a mean age of 29.3 years was conducted. Evaluation included ultrasound examinations at 11-14, 18-22, and 30-34 weeks to assess fetal development, amniotic fluid volume, and fetal and placental position. Doppler ultrasound of the uteroplacental blood flow with color Doppler mapping was used in the second and third trimesters to detect placental insufficiency and hypoxia. Two groups were compared. Results indicate that Doppler ultrasound and ultrasound imaging are effective in assessing blood flow and vascular resistance, allowing for early detection of hemodynamic disturbances. Conclusion: Morphological data suggest that key factors in the pathogenesis of placental insufficiency include Doppler hemodynamic indices and placental angioarchitecture. In the absence of blood flow abnormalities, endothelial dysfunction is considered compensated, implying favorable perinatal outcomes.
References
Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S; International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018 Jun;72(1):24-43.
Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019 Oct 24;366.
Bakrania B.A., Spradley F.T., Drummond H.A. et al. Preeclampsia: linking placental ischemia with maternal endothelial and vascular dysfunction. Compr Physiol. 2021;11(1):1315-1349. DOI: 10.1002/cphy.c200008.
Ghosh GS, Gudmundsson S. Uterine and umbilical artery Doppler are comparable in predicting perinatal outcome of growth-restricted fetuses. BJOG 2009; 116:424–430.
Qu H., Khalil R.A. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia. Am. J. Physiol. Heart Circ. Physiol. 2020;319:H661–H681.
Tropea T., Mavichak W., Evangelinos A., Brennan-Richardson Ch., Cottrell E. C., Jenny E. Myers, Johnstone E. D., Brownbill P. Fetoplacental vascular effects of maternal adrenergic antihypertensive and cardioprotective medications in pregnancy. J Hypertens. 2023 Nov; 41(11): 1675–1687.
Staff A. C. The two-stage placental model of preeclampsia: An update. J Reprod Immunol. 2019 Sep:134-135:1-10.
Akulenko L.V., Dzansolova A.B., Mugadova 3.B. Personalized approach to predicting preeclampsia // Problems of reproduction. 2017. T. 23. No. 2. P. 84-87. EDN: YOATQB.
Makarov O.V., Volkova E.V., Lysyuk E.Yu. and others. The role of angiogenic growth factors in the pathogenesis of preeclampsia and placental insufficiency. Obstetrics and gynecology. 2014;12:64-70.
